Trump’s Plan to Expand Access to Weight-Loss Drugs Just Hit a Major Roadblock
Medicare’s proposed pilot to cover GLP-1 drugs like Wegovy and Zepbound has been delayed.
Original Source
Read the full article at Inc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.